Figure 6.
Figure 6. Flt3L treatment also augments ILC type 2 cells in reconstituted BRGSF mice. (A) Representative flow cytometry analysis of GATA-3+ ILCs in lung of reconstituted BRGSF mice treated or not with Flt3L. (B) Frequency among hCD45+ cells and total number of GATA-3+ ILCs in lung of reconstituted BRGSF mice treated or not with Flt3L. Composite data from 8 mice of 2 experiments is shown. (C) Representative functional analysis by IL-13 intracellular flow cytometry from freshly isolated lung ILCs, after P/I ex vivo stimulation, and after in vivo hydrodynamic cytokine injection and ex vivo stimulation. (D) Expression of CRTh2, CCR6, CD56, and CD117 (histograms) on lung GATA-3 ILCs (red) and EOMES+TBET+ NK cells (gray) assessed by flow cytometry. Each dot represents 1 mouse. Numbers in plots represent frequencies within gates. Max, maximum; w/o, without.

Flt3L treatment also augments ILC type 2 cells in reconstituted BRGSF mice. (A) Representative flow cytometry analysis of GATA-3+ ILCs in lung of reconstituted BRGSF mice treated or not with Flt3L. (B) Frequency among hCD45+ cells and total number of GATA-3+ ILCs in lung of reconstituted BRGSF mice treated or not with Flt3L. Composite data from 8 mice of 2 experiments is shown. (C) Representative functional analysis by IL-13 intracellular flow cytometry from freshly isolated lung ILCs, after P/I ex vivo stimulation, and after in vivo hydrodynamic cytokine injection and ex vivo stimulation. (D) Expression of CRTh2, CCR6, CD56, and CD117 (histograms) on lung GATA-3 ILCs (red) and EOMES+TBET+ NK cells (gray) assessed by flow cytometry. Each dot represents 1 mouse. Numbers in plots represent frequencies within gates. Max, maximum; w/o, without.

Close Modal

or Create an Account

Close Modal
Close Modal